Joel Sheinfeld, MD

I have developed surgical techniques to preserve patients’ fertility through the use of “nerve sparing” retroperitoneal lymph node dissection (RPLND). This approach is appropriate for most patients who have low-stage disease and for many patients with more-advanced cancers who have completed treatment with chemotherapy. For the past decade I have performed approximately 100 RPLNDs per year. Because of my particular expertise in retroperitoneal surgery, I also work with specialists in other disciplines to surgically manage different types of tumors in the retroperitoneum.

I have written numerous articles and book chapters on testicular cancer care and frequently speak on the topic at national and international forums. As an established leader in testicular cancer I have edited special editions on this disease in Urologic Clinics of North America, the World Journal of Urology, the British Journal of Urology, Urologic Oncology, and Seminars in Urologic Oncology. Furthermore, I have written or co-authored the chapter on the surgical management of testicular cancer for the major textbooks in urology (Campbell’s Urology, 8th, 9th, and 10th editions) and oncology (DeVita’s Principles and Practice of Oncology, 5th, 6th, 7th, 8th, and 9th editions).

I serve as faculty director for the course on testicular cancer for the American Urological Association and am a member of the National Comprehensive Cancer Network’s guidelines committee for testicular cancer and kidney cancer.

I am an associate editor of Urology and World Journal of Urology and a reviewer for numerous peer-reviewed journals. I am an active member of the American Association of Urology and the Society of Urologic Oncology (of which I am a former board member). I also hold an appointment as Professor in the Department of Urology at Weill Cornell Medical College and Adjunct Professor at SUNY Downstate Medical Center.